---

Dr. Jo Varshney is the Founder and CEO of VeriSIM Life and a recognized leader in the field of AI driven drug development. Raised in a pharmacological family in India, she developed an early fascination with the intersection of biology and technology – a curiosity that grew into a lifelong mission to make drug development more predictive, humane and effective.

She is a veterinarian and earned a PhD in comparative oncology and genomics from the University of Minnesota, and pursued advanced training in comparative pathology and computational sciences at Penn State and UCSF.

Varshney founded VeriSIM Life to close the critical gap between preclinical research and clinical success. As the inventor of BIOiSIM®, a first-of-its-kind biosimulation platform, she has transformed how new medicines are developed, reducing reliance on animal testing, shortening research timelines by an average of 2.5 years and saving more than $3 million per program on the path to IND readiness. The BIOiSIM platform has been validated through collaborations with the NIH and leading pharmaceutical companies, advancing new therapies in oncology, pulmonary hypertension and addiction.

Her visionary leadership has earned broad recognition, including being named among the Top 100 Women in AI and Most Influential Women in Business by the San Francisco Business Times. A sought-after keynote speaker and thought leader, Varshney is deeply committed to advancing diversity, equity and inclusion in science and entrepreneurship and to inspiring the next generation of innovators who will shape the future of medicine.